The size of a man’s waistband is a better predictor of cancer risk than traditional body mass index (BMI) measurements, ...

We are happy to say that tomorrow he will be at home,” Dr. Sergio Alfieri, the head of the team taking care of the pontiff ...

A lawyer who represents a number of Lucy Letby's bereaved victims has shared his clients' agonising ordeal as the Thirwall ...

Data from the SAPPHIRE study formed the basis of Scholar Rock's U.S. Food and Drug Administration request to approve ...

Clinical research organisation (CRO) Icon has begun the integration of Medidata Clinical Data Studio into its clinical ...

Pliant Therapeutics has discontinued a pivotal Phase 2b/3 clinical trial evaluating bexotegrast as an IPF treatment.

Medtronic’s VenaSeal Spectrum postmarket clinical trial program is highlighting the need for further patient-centric ...

The evolution of the safety and effectiveness evaluation of endovascular grafts intended for abdominal aortic aneurysm repair ...

A new study has revealed that more than half of the claims on TikTok about attention deficit hyperactivity disorder (ADHD) ...

Goldman Sachs downgraded Icon (ICLR) to Neutral from Buy with a price target of $200, down from $250. While the firm continues to believe that ...

ICON Public Limited (NASDAQ:ICLR – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the fifteen ...

Signs of neurological damage over time may not be needed for a diagnosis of MS in patients who strongly meet other criteria, ...